Advertisement
Screener

ALIGNMENT HEALTHCARE, INC. (ALHC) EBITDA

Alignment Healthcare, Inc. EBITDA

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of the cash a company's operations generate before accounting charges for wearing out its assets. Here it is operating income plus the filed depreciation and amortization, not a figure the company adjusted itself. Higher EBITDA means more operating profit before those charges. It is not an official accounting (GAAP) measure and does not subtract capital spending, interest or tax, so it does not show what those obligations cost.

  • Alignment Healthcare, Inc. ebitda for the quarter ending 2026-06-30 was $49.95M, a 67.91% increase year-over-year.
  • Alignment Healthcare, Inc. ebitda for the quarter ending 2026-03-31 was $23.34M, a 960.52% increase year-over-year.
  • Alignment Healthcare, Inc. ebitda for the quarter ending 2025-12-31 was -$2.45M, a change of $13.33M year-over-year.
  • Alignment Healthcare, Inc. ebitda for the quarter ending 2025-09-30 was $15.66M, a change of $27.54M year-over-year.
  • Alignment Healthcare, Inc. ebitda for fiscal 2025 was $45.16M, a change of $119.84M from fiscal 2024.
  • Alignment Healthcare, Inc. ebitda for fiscal 2024 was -$74.68M, a change of $31.72M from fiscal 2023.
  • Alignment Healthcare, Inc. ebitda for fiscal 2023 was -$106.4M, a change of $4.96M from fiscal 2022.
  • Alignment Healthcare, Inc. ebitda for fiscal 2022 was -$111.37M, a change of $50.89M from fiscal 2021.
Available history
2019-12-31 to 2026-06-30
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported$49.95M$42.1M$7.85M(m)3.74%$10.14M*-$17.31M*(m)(m)$131.00M$1.27M
2026-03-31Reported$23.34M$15.5M$7.84M(m)1.89%$7.36M$128.68M(m)(m)$121.14M$25.00K
2025-12-31Reported-$2.45M-$10.28M$7.83M(m)-0.24%(m)(m)(m)(m)(m)(m)
2025-09-30Reported$15.66M$7.68M$7.98M(m)1.58%$5.50M*$144.56M*(m)(m)$110.02M$2.00K
2025-06-30Reported$29.75M$22.75M$7M(m)2.93%$8.00M*$29.13M*(m)(m)$103.80M$3.22M
2025-03-31Reported$2.2M-$5.39M$7.59M(m)0.24%$8.25M$16.62M(m)(m)$103.83M$21.00K
2024-12-31Reported-$15.78M-$22.55M$6.76M(m)-2.25%(m)(m)(m)(m)(m)(m)
2024-09-30Reported-$11.88M-$19.52M$7.64M(m)-1.72%$9.28M*$26.19M*(m)(m)$90.87M-$8.00K
2024-06-30Reported-$11.89M-$18.38M$6.49M(m)-1.75%$11.73M*$23.53M*(m)(m)$87.86M$22.00K
2024-03-31Reported-$35.13M-$41.11M$5.98M(m)-5.59%$11.12M-$6.24M(m)(m)$90.51M$0.00
2023-12-31Reported-$36.11M-$41.91M$5.8M(m)-7.87%(m)(m)(m)(m)(m)(m)
2023-09-30Reported-$24.26M-$29.76M$5.5M(m)-5.39%$9.55M*$5.99M*(m)(m)$83.09M$0.00
2023-06-30Reported-$18.46M-$23.66M$5.2M(m)-4.04%$8.56M*$37.18M*(m)(m)$70.20M$1.00K
2023-03-31Reported-$27.57M-$32.49M$4.92M(m)-6.34%$7.29M$85.11M(m)(m)$70.41M$1.00K
2022-12-31Reported-$47.42M-$52.11M$4.69M(m)-13.17%(m)(m)(m)(m)(m)(m)
2022-09-30Reported-$28.95M-$33.41M$4.46M(m)-8.04%(m)$105.12M*(m)(m)$76.45M$167.00K
2022-06-30Reported-$2.47M-$6.65M$4.18M(m)-0.67%(m)$10.35M*(m)(m)$61.67M$0.00
2022-03-31Reported-$32.53M-$36.48M$3.95M(m)-9.42%(m)-$11.64M(m)(m)$74.29M$0.00
2021-12-31Reported-$39.38M-$43.47M$4.09M(m)-13.21%(m)(m)(m)(m)(m)(m)
2021-09-30Reported-$37.37M-$41.45M$4.08M(m)-12.74%(m)$12.91M*(m)(m)$76.85M$0.00
2021-06-30Reported-$36.58M-$40.49M$3.91M(m)-11.85%(m)-$23.45M*(m)(m)$71.15M$0.00
2021-03-31Reported-$48.93M-$52.66M$3.74M(m)-18.32%(m)-$38.11M(m)(m)$64.91M$0.00
2020-12-31Reported-$23.72M-$27.8M$4.07M(m)-9.82%(m)(m)(m)(m)(m)(m)
2020-09-30Reported$18.99M$15.06M$3.93M(m)7.74%(m)$26.04M*(m)(m)$38.79M$0.00
2020-06-30Reported$16.11M$12.59M$3.53M(m)6.60%(m)$13.49M*(m)(m)$33.70M$0.00
2020-03-31Reported-$1.55M-$5.12M$3.57M(m)-0.69%(m)-$21.82M(m)(m)$32.79M$0.00

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported$45.16M$14.75M$30.4M(m)1.14%$26.78M$139.93M(m)(m)$443.41M$20.00K
2024-12-31Reported-$74.68M-$101.56M$26.87M(m)-2.76%$41.42M$34.77M(m)(m)$371.37M$21.00K
2023-12-31Reported-$106.4M-$127.82M$21.41M(m)-5.91%$35.99M-$59.19M(m)(m)$307.43M-$22.00K
2022-12-31Reported-$111.37M-$128.64M$17.27M(m)-7.78%$23.77M-$45.43M(m)(m)$295.65M$339.00K
2021-12-31Reported-$162.26M-$178.07M$15.81M(m)-13.90%(m)-$78.78M(m)(m)$290.99M$0.00
2020-12-31Reported$9.83M-$5.26M$15.1M(m)1.03%(m)$7.56M(m)(m)$156.40M$0.00
2019-12-31Reported-$14.56M-$29.48M$14.92M(m)-1.93%(m)$9.21M(m)(m)$110.13M$0.00

Similar stocks

Stock NameCountryMarket CapPE Ratio
TRUPANION, INC. (TRUP)United States$0.984B
MOLINA HEALTHCARE, INC. (MOH)United States$10.091B-1,697.50
CENTENE CORP (CNC)United States$30.588B-6.22
HUMANA INC (HUM)United States$45.651B18.44
Cigna Group (CI)United States$70.160B10.44
Elevance Health, Inc. (ELV)United States$86.364B16.90
UNITEDHEALTH GROUP INC (UNH)United States$336.652B26.62